1. Home
  2. DTM vs MDGL Comparison

DTM vs MDGL Comparison

Compare DTM & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DT Midstream Inc.

DTM

DT Midstream Inc.

HOLD

Current Price

$129.49

Market Cap

13.2B

Sector

Utilities

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$534.92

Market Cap

12.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTM
MDGL
Founded
2021
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
12.8B
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
DTM
MDGL
Price
$129.49
$534.92
Analyst Decision
Buy
Strong Buy
Analyst Count
11
12
Target Price
$142.82
$674.45
AVG Volume (30 Days)
904.7K
214.6K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
2.54%
N/A
EPS Growth
19.44
N/A
EPS
2.36
N/A
Revenue
$1,243,000,000.00
$180,133,000.00
Revenue This Year
$7.56
$58.39
Revenue Next Year
$5.98
$48.55
P/E Ratio
$55.13
N/A
Revenue Growth
26.71
N/A
52 Week Low
$104.26
$393.61
52 Week High
$152.88
$615.00

Technical Indicators

Market Signals
Indicator
DTM
MDGL
Relative Strength Index (RSI) 41.55 48.19
Support Level $116.71 $499.26
Resistance Level $150.63 $545.13
Average True Range (ATR) 3.43 17.53
MACD 0.36 0.24
Stochastic Oscillator 48.69 43.24

Price Performance

Historical Comparison
DTM
MDGL

About DTM DT Midstream Inc.

DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates maximum revenue from pipeline segment that includes interstate pipelines, storage systems, gathering lateral pipelines and compression and surface facilities.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: